Srinivasan Thangathirupathy

This inventor holds 13 USPTO granted patents and 10 published patent applications and 6 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Syngene International Limited, Viiv Healthcare UK (No.5) Limited. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Srinivasan Thangathirupathy. Retrieved from https://idiyas.com/inventor/srinivasan-thangathirupathy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 10)

% Patents Active = 92.3

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 8.7

ph-index = 2

Forward Citations = 28(Granted Patents)

Location History:

Bengaluru, IN (2014 - 2019)
Hosur, IN (2015 - 2022)

Company Filing History:

13 out of 3,742

Bristol-Myers Squibb Compnay

patents

1 out of 7

Syngene International Limited

patents

1 out of 45

Viiv Healthcare UK (No.5) Limited

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12473304 - Heterocyclic PAD4 inhibitors (2025-11-18),

2. 11253525 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use (2022-02-22),

3. 10961229 - Selective NR2B antagonists (2021-03-30),

4. 10959986 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use (2021-03-30),

5. 10954225 - Selective NR2B antagonists (2021-03-23),

6. 10501451 - Selective NR2B antagonists (2019-12-10),

7. 10399932 - Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer (2019-09-03),

8. 10344020 - Selective NR2B antagonists (2019-07-09),

9. 10221129 - Inhibitors of human immunodeficiency virus replication (2019-03-05),

10. 10167254 - IDO inhibitors (2019-01-01),

11. 9790169 - IDO inhibitors (2017-10-17),

12. 9221796 - Selective NR2B antagonists (2015-12-29),

13. 8722670 - Selective NR2B antagonists (2014-05-13),

Title: **Inventor Profile: Srinivasan Thangathirupathy**

Introduction

Srinivasan Thangathirupathy is a prominent inventor based in Hosur, India, known for his significant contributions to the field of pharmaceutical innovations. With a portfolio of 12 patents, he has demonstrated his expertise in developing compounds that have the potential to address critical health challenges.

Latest Patents

His latest patents focus on the "Inhibitors of indoleamine 2,3-dioxygenase and methods of their use." These patents disclose compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO). The pharmaceutical compositions containing these compounds are aimed at treating proliferative disorders, such as cancer, viral infections, and inflammatory disorders.

Career Highlights

Srinivasan has worked with distinguished companies such as Bristol-Myers Squibb Company and Syngene International Limited. His experience at these organizations has equipped him with a wealth of knowledge in drug development and innovative research methodologies.

Collaborations

Throughout his career, Srinivasan has collaborated with notable colleagues, including Srinivas Cheruku and Jayakumar Sankara Warrier. These partnerships have played a crucial role in his research endeavors and patent developments.

Conclusion

Srinivasan Thangathirupathy's work in the pharmaceutical industry has garnered recognition and respect, particularly for his innovative solutions to complex medical issues. His contributions, encapsulated in his patents, continue to shape the landscape of therapeutic development.

Profile summary based on public USPTO records.